By and large, these studies with multiple genetic manipulation models demonstrate the role of GCS in cancer cell response to heterocyclic chemotherapy drugs, the very drugs that promote the expression of P-gp and related drug pumps [138]. This evidence concerns the gene PGP and cancer.